Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Collegium Pharmaceutical (COLL) Operating Margin: 2016-2025

Historic Operating Margin for Collegium Pharmaceutical (COLL) over the last 10 years, with Sep 2025 value amounting to 29.66%.

  • Collegium Pharmaceutical's Operating Margin rose 779.00% to 29.66% in Q3 2025 from the same period last year, while for Sep 2025 it was 20.74%, marking a year-over-year decrease of 1155.00%. This contributed to the annual value of 26.91% for FY2024, which is 255.00% down from last year.
  • According to the latest figures from Q3 2025, Collegium Pharmaceutical's Operating Margin is 29.66%, which was up 58.82% from 18.67% recorded in Q2 2025.
  • In the past 5 years, Collegium Pharmaceutical's Operating Margin registered a high of 41.20% during Q4 2023, and its lowest value of -124.71% during Q4 2021.
  • For the 3-year period, Collegium Pharmaceutical's Operating Margin averaged around 26.14%, with its median value being 26.29% (2023).
  • Its Operating Margin has fluctuated over the past 5 years, first slumped by 14,437bps in 2021, then spiked by 13,378bps in 2022.
  • Over the past 5 years, Collegium Pharmaceutical's Operating Margin (Quarterly) stood at -124.71% in 2021, then surged by 13,378bps to 9.07% in 2022, then soared by 3,213bps to 41.20% in 2023, then slumped by 2,025bps to 20.95% in 2024, then skyrocketed by 779bps to 29.66% in 2025.
  • Its last three reported values are 29.66% in Q3 2025, 18.67% for Q2 2025, and 12.20% during Q1 2025.